GHRP-2 Acetate
Research use only.
High-purity research-grade GHRP-2 Acetate
GHRP-2 Acetate is a synthetic growth hormone-releasing peptide widely studied for its ability to stimulate endogenous growth hormone (GH) secretion and support anabolic signaling pathways. As a potent ghrelin receptor agonist, GHRP-2 is commonly explored in research involving muscle growth, recovery, body composition, sleep quality, and metabolic function. Its strong GH-releasing properties have made it a prominent compound in peptide and endocrine research.
Product overview
GHRP-2 Acetate is a hexapeptide belonging to the growth hormone secretagogue (GHS) class of compounds. It functions by binding to the ghrelin/growth hormone secretagogue receptor (GHS-R1a), stimulating pulsatile release of growth hormone from the pituitary gland. Research investigating GHRP-2 has focused on its potential anabolic, recovery-supportive, and metabolic effects in experimental models involving growth hormone deficiency, muscle wasting, and age-related hormonal decline.
Key research features
Supports endogenous growth hormone release: Studies indicate GHRP-2 may significantly increase natural growth hormone secretion, contributing to elevated IGF-1 production and enhanced anabolic activity. These effects have made it a widely studied compound in performance and recovery-focused research.
Recovery and tissue support: Research suggests GHRP-2 may assist in supporting muscle repair, connective tissue recovery, and overall regenerative processes. Experimental findings indicate potential benefits for post-exercise recovery and injury-related tissue healing.
Body composition and metabolic research: By influencing growth hormone pathways, GHRP-2 has been investigated for its potential role in supporting lean muscle development, fat metabolism, and improved nutrient utilization. Early studies also suggest possible effects on energy balance and metabolic efficiency.
Sleep and appetite modulation: As a ghrelin receptor agonist, GHRP-2 may influence appetite signaling and sleep architecture. Research has explored its potential to enhance deep sleep quality, a key period associated with endogenous growth hormone release and physiological recovery.
GHRP-2 Acetate Suggested Use:
Typical Dose: 100–300 mcg per administration
Route: Subcutaneous injection
Frequency: 1–3 times daily
Duration: 4–12 weeks, or as recommended by a healthcare professional